BeOne Medicines (BEIGF) Debt Ratio (2015 - 2026)

BeOne Medicines (BEIGF) has reported Debt Ratio for 12 consecutive years, with 0.12 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Debt Ratio fell 22.83% year-over-year to 0.12 in Q2 2026; TTM through Jun 2026 was 0.12, a 22.83% decrease from a year earlier, with the FY2025 full-year figure at 0.12, down 60.58% from the prior year.
• Debt Ratio was 0.12 for Q2 2026 at BeOne Medicines, down from 0.13 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.32 in Q3 2025 and troughed at 0.08 in Q1 2022.
• A 5-year average of 0.15 and a median of 0.13 in 2025 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio soared 120.92% in 2024 and slumped 60.58% in 2025, its largest moves.
• Over 5 years, Debt Ratio stood at 0.08 in 2022, then surged by 80.93% to 0.15 in 2023, then jumped by 106.89% to 0.32 in 2024, then slumped by 60.58% to 0.12 in 2025, then dropped by 6.04% to 0.12 in 2026.
• The last three Debt Ratio figures came in at 0.12 (Q2 2026), 0.13 (Q1 2026), and 0.12 (Q4 2025), per Business Quant data.